Journal of the Society for Cardiovascular Angiography & Interventions最新文献

英文中文

Dr George L. Bakris, 1952-2024 乔治-L-巴克里斯博士，1952-2024 年

Journal of the Society for Cardiovascular Angiography & Interventions

Pub Date : 2024-10-01 DOI: 10.1016/j.jscai.2024.102279

Michael H. Davidson MD

引用次数: 0

Corrigendum to “Intra-cardiac echocardiography-guided percutaneous aspiration of tricuspid vegetations” [JSCAI 3/3PA(2024):101291] 心内超声心动图引导下经皮抽吸三尖瓣植物 "的更正 [JSCAI 3/3PA(2024):101291]

Journal of the Society for Cardiovascular Angiography & Interventions

Pub Date : 2024-10-01 DOI: 10.1016/j.jscai.2024.102290

Zach Rozenbaum MD

引用次数: 0

Maneuvering Through the Uncertainty of Deep Vein Thrombosis Interventions: An Encouraging Contemporary Analysis 穿越深静脉血栓干预的不确定性：令人鼓舞的当代分析

Journal of the Society for Cardiovascular Angiography & Interventions

Pub Date : 2024-10-01 DOI: 10.1016/j.jscai.2024.102287

Giorgio A. Medranda MD , Sahil A. Parikh MD , Hady Lichaa MD

引用次数: 0

The Beneficial Atrial Septal Defect Shunt in Hypertrophic Cardiomyopathy—When Closure Is Not the Answer 肥厚型心肌病中的有益心房间隔缺损分流术--当关闭心房间隔缺损并不能解决问题时

Journal of the Society for Cardiovascular Angiography & Interventions

Pub Date : 2024-10-01 DOI: 10.1016/j.jscai.2024.102281

Mohammad Alnoor MD, Ahmed Deniwar MD, Sherzana Sunderji MD

引用次数: 0

Hemodynamic Assessment and Transcatheter Intervention Treating Pulmonary Vein Stenosis 血液动力学评估和经导管介入治疗肺静脉狭窄

Journal of the Society for Cardiovascular Angiography & Interventions

Pub Date : 2024-10-01 DOI: 10.1016/j.jscai.2024.102250

Ashish H. Shah MD, MD-Research (UK), FRCP (UK) , Triston Eastman MD , Petra Jenkins MD, FRCP (UK)

引用次数: 0

Long-Term Adverse Limb Events After Femoral Artery Endovascular Revascularization: The Boston FAROUT Study 股动脉血管内再通术后的长期肢体不良事件：波士顿 FAROUT 研究

Journal of the Society for Cardiovascular Angiography & Interventions

Pub Date : 2024-10-01 DOI: 10.1016/j.jscai.2024.102241

Edwin Mandieka MD , Ramael Ohiomoba MD, MPH , Piotr Sobieszczyk MD , Andrew C. Eisenhauer MD , Thomas Todoran MD , Scott Kinlay MBBS, PhD

Background

: Patient, lesion, and procedural characteristics may impact the long-term risks of adverse limb outcomes differently after successful endovascular revascularization for lower extremity peripheral artery disease. The study objective was to assess the relationships of patient, lesion, and procedural characteristics to the subsequent risk of major and minor adverse limb events over the decade after successful endovascular revascularization of the superficial femoral artery for chronic limb-threatening ischemia (CLTI) or lifestyle-limiting claudication.

Methods

A retrospective cohort of patients who underwent endovascular revascularization between 2003-2011 were followed for a median of 9.3 (IQR, 6.8-11.1) years. Hazard ratios (HR) and 95% CI from Cox proportional hazards models assessed the risk of major adverse limb events (MALE) (major amputation, bypass, or thrombolysis) or minor revascularization, MALE alone, and minor revascularization alone.

Results

There were 232 index limb revascularizations in 185 patients. Longer lesion length was associated with a higher risk of MALE or minor revascularization (HR, 2.09; 95% CI, 1.22-3.60) and minor revascularization alone (HR, 2.53; 95% CI, 1.39-4.61). Current smoking was linked with minor revascularization (HR, 3.83; 95% CI, 1.54-9.56). CLTI was associated with MALE or minor revascularization (HR, 1.89; 95% CI, 1.09-3.29), and MALE alone (HR, 7.43; 95% CI, 3.11-17.79). Black race/ethnicity (HR, 4.74; 95% CI, 1.51-14.9) and low-density lipoprotein >100 mg/dL (HR, 2.76; 95% CI, 1.20-6.35) were linked to MALE alone.

Conclusions

Factors related to MALE differed from those related to minor revascularization. Lesion length and smoking were linked to minor revascularization, whereas CLTI, Black race/ethnicity, and elevated low-density lipoprotein were linked to MALE.

背景：成功进行下肢外周动脉血管再通术后，患者、病变和手术特征可能会对肢体不良后果的长期风险产生不同的影响。该研究的目的是评估患者、病变和手术特征与因慢性肢体威胁性缺血（CLTI）或生活方式限制性跛行而成功接受股浅动脉血管内再通术后十年内发生主要和次要肢体不良事件的风险之间的关系。方法：对2003-2011年间接受血管内再通术的患者进行回顾性队列随访，随访时间中位数为9.3年（IQR，6.8-11.1年）。Cox比例危险模型得出的危险比（HR）和95% CI评估了肢体重大不良事件（MALE）（重大截肢、搭桥或溶栓）或轻微血管再通、单纯MALE和单纯轻微血管再通的风险。病变长度越长，接受MALE或小血管再通手术（HR，2.09；95% CI，1.22-3.60）和单纯小血管再通手术（HR，2.53；95% CI，1.39-4.61）的风险越高。目前吸烟与轻微血管再通术有关（HR，3.83；95% CI，1.54-9.56）。CLTI与男性或轻微血管再通有关（HR，1.89；95% CI，1.09-3.29），也与仅男性有关（HR，7.43；95% CI，3.11-17.79）。黑人种族/民族（HR，4.74；95% CI，1.51-14.9）和低密度脂蛋白100 mg/dL（HR，2.76；95% CI，1.20-6.35）与单纯MALE相关。病变长度和吸烟与轻微血管再通有关，而CLTI、黑人种族/族裔和低密度脂蛋白升高与MALE有关。

{"title":"Long-Term Adverse Limb Events After Femoral Artery Endovascular Revascularization: The Boston FAROUT Study","authors":"Edwin Mandieka MD , Ramael Ohiomoba MD, MPH , Piotr Sobieszczyk MD , Andrew C. Eisenhauer MD , Thomas Todoran MD , Scott Kinlay MBBS, PhD","doi":"10.1016/j.jscai.2024.102241","DOIUrl":"10.1016/j.jscai.2024.102241","url":null,"abstract":"<div><h3>Background</h3><div>: Patient, lesion, and procedural characteristics may impact the long-term risks of adverse limb outcomes differently after successful endovascular revascularization for lower extremity peripheral artery disease. The study objective was to assess the relationships of patient, lesion, and procedural characteristics to the subsequent risk of major and minor adverse limb events over the decade after successful endovascular revascularization of the superficial femoral artery for chronic limb-threatening ischemia (CLTI) or lifestyle-limiting claudication.</div></div><div><h3>Methods</h3><div>A retrospective cohort of patients who underwent endovascular revascularization between 2003-2011 were followed for a median of 9.3 (IQR, 6.8-11.1) years. Hazard ratios (HR) and 95% CI from Cox proportional hazards models assessed the risk of major adverse limb events (MALE) (major amputation, bypass, or thrombolysis) or minor revascularization, MALE alone, and minor revascularization alone.</div></div><div><h3>Results</h3><div>There were 232 index limb revascularizations in 185 patients. Longer lesion length was associated with a higher risk of MALE or minor revascularization (HR, 2.09; 95% CI, 1.22-3.60) and minor revascularization alone (HR, 2.53; 95% CI, 1.39-4.61). Current smoking was linked with minor revascularization (HR, 3.83; 95% CI, 1.54-9.56). CLTI was associated with MALE or minor revascularization (HR, 1.89; 95% CI, 1.09-3.29), and MALE alone (HR, 7.43; 95% CI, 3.11-17.79). Black race/ethnicity (HR, 4.74; 95% CI, 1.51-14.9) and low-density lipoprotein >100 mg/dL (HR, 2.76; 95% CI, 1.20-6.35) were linked to MALE alone.</div></div><div><h3>Conclusions</h3><div>Factors related to MALE differed from those related to minor revascularization. Lesion length and smoking were linked to minor revascularization, whereas CLTI, Black race/ethnicity, and elevated low-density lipoprotein were linked to MALE.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"3 10","pages":"Article 102241"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142528928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Addressing Knowledge Gaps in Patients With High-Risk Peripheral Artery Disease 缩小高危外周动脉疾病患者的知识差距

Journal of the Society for Cardiovascular Angiography & Interventions

Pub Date : 2024-10-01 DOI: 10.1016/j.jscai.2024.102286

R. Kevin Rogers MD, MSc , Marc P. Bonaca MD, MPH

引用次数: 0

Outcome of Saphenous Vein Graft Percutaneous Coronary Intervention Using Contemporary Drug-Eluting Stents: A SCAAR Report 使用当代药物洗脱支架进行隐静脉移植经皮冠状动脉介入治疗的结果：SCAAR 报告

Journal of the Society for Cardiovascular Angiography & Interventions

Pub Date : 2024-10-01 DOI: 10.1016/j.jscai.2024.102232

Saman Saidi-Seresht MD , Stefan James MD, PhD , David Erlinge MD, PhD , Sasha Koul MD, PhD , Bo Lagerqvist MD, PhD , Moman Mohammad MD, PhD , Henrik Renlund PhD , Per Grimfjärd MD, PhD

Background

Percutaneous coronary intervention (PCI) of saphenous vein grafts (SVG) is associated with poor outcomes and is often regarded as inferior to native vessel PCI. We investigated clinical outcomes of SVG-PCI using contemporary drug-eluting stents (DES), in a complete, nationwide population.

Methods

The complete Swedish Coronary Angiography and Angioplasty Registry (SCAAR) was used to identify all patients in Sweden who underwent SVG-PCI with a contemporary DES between 2013 and 2020. Baseline characteristics, procedures, and outcomes were described.

Results

A total of 2198 SVG-PCI procedures with 3106 contemporary DES were included. Patients had a high incidence of comorbidities such as diabetes (40%), prior myocardial infarction (MI) (69%), and acute coronary syndrome (74%) at presentation. SVG-PCI procedures commonly involved multiple DES (41%). Native vessel PCI, in addition to SVG-PCI, was performed in only 13% of procedures. At 1 year, adverse clinical outcomes were frequent as exemplified by any death (9.2%), MI (9.1%), or revascularization (21.1%), whereas stent and lesion-related outcomes on a patient level were less common: stent thrombosis (1.2%), in-stent restenosis (4.3%) and target lesion revascularization (4.3%). Similarly, at 3 years, clinical outcomes were frequent: death (19.8%), MI (21.1%), revascularization (32.8%); and stent-related outcomes were less common: stent thrombosis (2.9%), restenosis (10.8), and target lesion revascularization (13.6%).

Conclusions

In this nationwide cohort of patients who underwent SVG-PCI with contemporary DES, patients were characterized by a high-risk profile and high rates of adverse clinical events. However, the incidence of stent and lesion-related events was low.

背景大隐静脉移植物（SVG）经皮冠状动脉介入治疗（PCI）的疗效不佳，通常被认为不如原血管PCI。我们在一个完整的全国性人群中调查了使用现代药物洗脱支架（DES）进行SVG-PCI的临床疗效。方法利用完整的瑞典冠状动脉造影和血管成形术登记处（SCAAR）来识别2013年至2020年间瑞典所有使用现代DES进行SVG-PCI的患者。结果共纳入了2198例使用3106个当代DES的SVG-PCI手术。患者发病时合并糖尿病（40%）、既往心肌梗死（69%）和急性冠脉综合征（74%）的比例较高。SVG-PCI手术通常涉及多个DES（41%）。除SVG-PCI外，仅有13%的手术进行了原发血管PCI。1年后，不良临床结果频频出现，如死亡（9.2%）、心肌梗死（9.1%）或血管再通（21.1%），而支架和病变相关的患者结果则较少见：支架血栓（1.2%）、支架内再狭窄（4.3%）和靶病变血管再通（4.3%）。同样，3年后的临床结果为：死亡（19.8%）、心肌梗死（21.1%）、血运重建（32.8%）；支架相关结果为：支架血栓（2.9%）、支架内再狭窄（10.8%）和靶病变血运重建（13.6%）。然而，支架和病变相关事件的发生率较低。

{"title":"Outcome of Saphenous Vein Graft Percutaneous Coronary Intervention Using Contemporary Drug-Eluting Stents: A SCAAR Report","authors":"Saman Saidi-Seresht MD , Stefan James MD, PhD , David Erlinge MD, PhD , Sasha Koul MD, PhD , Bo Lagerqvist MD, PhD , Moman Mohammad MD, PhD , Henrik Renlund PhD , Per Grimfjärd MD, PhD","doi":"10.1016/j.jscai.2024.102232","DOIUrl":"10.1016/j.jscai.2024.102232","url":null,"abstract":"<div><h3>Background</h3><div>Percutaneous coronary intervention (PCI) of saphenous vein grafts (SVG) is associated with poor outcomes and is often regarded as inferior to native vessel PCI. We investigated clinical outcomes of SVG-PCI using contemporary drug-eluting stents (DES), in a complete, nationwide population.</div></div><div><h3>Methods</h3><div>The complete Swedish Coronary Angiography and Angioplasty Registry (SCAAR) was used to identify all patients in Sweden who underwent SVG-PCI with a contemporary DES between 2013 and 2020. Baseline characteristics, procedures, and outcomes were described.</div></div><div><h3>Results</h3><div>A total of 2198 SVG-PCI procedures with 3106 contemporary DES were included. Patients had a high incidence of comorbidities such as diabetes (40%), prior myocardial infarction (MI) (69%), and acute coronary syndrome (74%) at presentation. SVG-PCI procedures commonly involved multiple DES (41%). Native vessel PCI, in addition to SVG-PCI, was performed in only 13% of procedures. At 1 year, adverse clinical outcomes were frequent as exemplified by any death (9.2%), MI (9.1%), or revascularization (21.1%), whereas stent and lesion-related outcomes on a patient level were less common: stent thrombosis (1.2%), in-stent restenosis (4.3%) and target lesion revascularization (4.3%). Similarly, at 3 years, clinical outcomes were frequent: death (19.8%), MI (21.1%), revascularization (32.8%); and stent-related outcomes were less common: stent thrombosis (2.9%), restenosis (10.8), and target lesion revascularization (13.6%).</div></div><div><h3>Conclusions</h3><div>In this nationwide cohort of patients who underwent SVG-PCI with contemporary DES, patients were characterized by a high-risk profile and high rates of adverse clinical events. However, the incidence of stent and lesion-related events was low.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"3 10","pages":"Article 102232"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142528919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

DETECT-DVT: Detroit Evaluation of Thrombectomy and Evaluation of Intravascular Ultrasound in Deep Vein Thrombosis DETECT-DVT：深静脉血栓形成中血栓切除术的底特律评估和血管内超声评估

Journal of the Society for Cardiovascular Angiography & Interventions

Pub Date : 2024-10-01 DOI: 10.1016/j.jscai.2024.102153

Sabina Kumar MS, DO , Brian Ballard DO , Umeh Chukwuemeka MD , Anthony Teta MD , Mustafa Turkmani MD , Anuraag Khandavalli MD , Samuel Reenders MS, DO , Arjun Chadha MD , Marian Canon MD , Saman Barznji MD , Jason Kaplan MD , Varun Yelamanchilli MD , Brandon Ballard BS , Mark Zainea MD , Jay Mohan DO

Background

We sought to evaluate the use of intravascular ultrasound (IVUS) and mechanical thrombectomy (MT) for the treatment of deep vein thrombosis (DVT) in a community hospital setting.

Methods

Data were analyzed among patients with lower extremity DVT who underwent MT from December 1, 2021 to December 1, 2022.

Results

A total of 1263 patients were evaluated and only 8.8% of patients with DVT received intervention. Of them, 42% were women. The mean age and length of stay were 61.3 years and 3.5 days, respectively. For cases that proceeded to intervention, IVUS was used in 89% of cases, 80% received venoplasty, and 30% received stents. The mean number of MT passes was 4 and the mean contrast volume used was 71 mL. Flow was restored in 96.7% of cases. The procedure was unable to be completed in 1.8% of the cases, and 1.8% had a reported complication after the procedure. Vascular surgery was consulted in 64.4% of the cases, cardiology in 33%, interventional radiology in 12.5%, and 10.9% of the patients had multiple consults. MT was associated with postprocedure reduction of hemoglobin levels (13.4 vs 12.1; P < .001) and no change in postprocedure creatinine levels (1.08 vs 1.04; P = .28). IVUS was associated with fewer passes, although this was not statistically significant (P = .09). Additionally, IVUS was associated with increased stenting (P = .03) and venoplasty (P < .001).

Conclusions

MT is shown to be successful in restoring venous flow and is utilized by multiple specialties in the treatment of DVT. Additionally, IVUS was widely used in conjunction with MT, and it was associated with increased advanced interventions, such as venoplasty and stent placement.

背景我们试图评估在社区医院环境中使用血管内超声（IVUS）和机械血栓切除术（MT）治疗深静脉血栓形成（DVT）的情况。方法对2021年12月1日至2022年12月1日期间接受MT治疗的下肢DVT患者的数据进行分析。其中，42%为女性。平均年龄和住院时间分别为 61.3 岁和 3.5 天。在进行介入治疗的病例中，89%使用了IVUS，80%接受了静脉成形术，30%接受了支架治疗。MT的平均通过次数为4次，平均造影剂用量为71毫升。96.7%的病例恢复了血流。1.8%的病例无法完成手术，1.8%的病例术后出现并发症。64.4%的病例咨询了血管外科，33%的病例咨询了心脏科，12.5%的病例咨询了介入放射科，10.9%的患者进行了多次咨询。MT 与术后血红蛋白水平降低有关（13.4 vs 12.1；P < .001），而术后肌酐水平无变化（1.08 vs 1.04；P = .28）。IVUS与较少的通过次数有关，但无统计学意义（P = .09）。此外，IVUS 与更多的支架植入术（P = .03）和静脉成形术（P < .001）相关。此外，IVUS 与 MT 结合使用非常广泛，而且与静脉成形术和支架置入术等高级干预措施的增加有关。

{"title":"DETECT-DVT: Detroit Evaluation of Thrombectomy and Evaluation of Intravascular Ultrasound in Deep Vein Thrombosis","authors":"Sabina Kumar MS, DO , Brian Ballard DO , Umeh Chukwuemeka MD , Anthony Teta MD , Mustafa Turkmani MD , Anuraag Khandavalli MD , Samuel Reenders MS, DO , Arjun Chadha MD , Marian Canon MD , Saman Barznji MD , Jason Kaplan MD , Varun Yelamanchilli MD , Brandon Ballard BS , Mark Zainea MD , Jay Mohan DO","doi":"10.1016/j.jscai.2024.102153","DOIUrl":"10.1016/j.jscai.2024.102153","url":null,"abstract":"<div><h3>Background</h3><div>We sought to evaluate the use of intravascular ultrasound (IVUS) and mechanical thrombectomy (MT) for the treatment of deep vein thrombosis (DVT) in a community hospital setting.</div></div><div><h3>Methods</h3><div>Data were analyzed among patients with lower extremity DVT who underwent MT from December 1, 2021 to December 1, 2022.</div></div><div><h3>Results</h3><div>A total of 1263 patients were evaluated and only 8.8% of patients with DVT received intervention. Of them, 42% were women. The mean age and length of stay were 61.3 years and 3.5 days, respectively. For cases that proceeded to intervention, IVUS was used in 89% of cases, 80% received venoplasty, and 30% received stents. The mean number of MT passes was 4 and the mean contrast volume used was 71 mL. Flow was restored in 96.7% of cases. The procedure was unable to be completed in 1.8% of the cases, and 1.8% had a reported complication after the procedure. Vascular surgery was consulted in 64.4% of the cases, cardiology in 33%, interventional radiology in 12.5%, and 10.9% of the patients had multiple consults. MT was associated with postprocedure reduction of hemoglobin levels (13.4 vs 12.1; <em>P</em> < .001) and no change in postprocedure creatinine levels (1.08 vs 1.04; <em>P</em> = .28). IVUS was associated with fewer passes, although this was not statistically significant (<em>P</em> = .09). Additionally, IVUS was associated with increased stenting (<em>P</em> = .03) and venoplasty (<em>P</em> < .001).</div></div><div><h3>Conclusions</h3><div>MT is shown to be successful in restoring venous flow and is utilized by multiple specialties in the treatment of DVT. Additionally, IVUS was widely used in conjunction with MT, and it was associated with increased advanced interventions, such as venoplasty and stent placement.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"3 10","pages":"Article 102153"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142528930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Successful Percutaneous Treatment of Left Main Artery Occlusion Associated With Focal Type A Aortic Dissection 成功经皮治疗伴有局灶性 A 型主动脉夹层的左主干动脉闭塞症

Journal of the Society for Cardiovascular Angiography & Interventions

Pub Date : 2024-10-01 DOI: 10.1016/j.jscai.2024.102293

Ashraf Samhan MD , Anjan Tibrewala MD , Anirudh Kumar MD

Type A aortic dissection is a rapidly progressive disease process with often fatal complications. We present a case of focal Type A aortic dissection complicated by left main occlusion and cardiogenic shock, treated with percutaneous coronary intervention and mechanical circulatory support.

A 型主动脉夹层是一种进展迅速的疾病，通常会出现致命的并发症。我们报告了一例局灶性 A 型主动脉夹层并发左主干闭塞和心源性休克的病例，患者接受了经皮冠状动脉介入治疗和机械循环支持治疗。

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Journal of the Society for Cardiovascular Angiography & Interventions

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀